TIERMODELLE UND THERAPEUTISCHE MOLEKÜLE

European patent · EP3794941 · In force

Register entry

Publication number
EP3794941
Application number
EP20191651
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 1, 2014
Published
Mar 24, 2021
Granted
Sep 25, 2024
Protection ends at the latest
Sep 30, 2034
Next annual fee due
Oct 31, 2027
IPC classes
A01K 67/027 (2024.01)
A61P 43/00 (2006.01)
C07K 16/46 (2006.01)
C12N 15/85 (2006.01)
C07K 16/00 (2006.01)
Priority
FR 1359518 01.10.2013
GB 201317410 01.10.2013
Divided from
EP14781635
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.10.2026 → 31.10.2027

    Published in Swissreg on 01.11.2026

  2. Nov 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.10.2025 → 31.10.2026

    Published in Swissreg on 01.11.2025

  3. Aug 6, 2025

    Change

    Published in Swissreg on 06.08.2025

  4. Nov 1, 2024

    Next annual fee due on

    Next annual fee due on
    31.10.2024 → 31.10.2025

    Published in Swissreg on 01.11.2024

  5. Sep 25, 2024

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 25.09.2024

Parties

Holder

Kymab Limited

The Bennet Building (B930) Babraham Research Campus, Cambridge CB22 3AT, GB

Inventor

LEE, E-Chiang

Cambridge CB22 3AT, GB

CLUBE, Jasper

Cambridge CB22 3AT, GB

BRADLEY, Allan

Cambridge CB22 3AT, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.